| # | Title | Journal | Year | Citations |
|---|
| 1 | How to use and assess qualitative research methods | Neurological Research and Practice | 2020 | 290 |
| 2 | Recovery from stroke: current concepts and future perspectives | Neurological Research and Practice | 2020 | 157 |
| 3 | Glymphatic system, AQP4, and their implications in Alzheimer’s disease | Neurological Research and Practice | 2021 | 88 |
| 4 | Safety and clinical impact of FEES – results of the FEES-registry | Neurological Research and Practice | 2019 | 73 |
| 5 | “Neurological manifestations of COVID-19” - guideline of the German society of neurology | Neurological Research and Practice | 2020 | 71 |
| 6 | Diagnosis of peripheral neuropathy | Neurological Research and Practice | 2020 | 55 |
| 7 | Computer-aided imaging analysis in acute ischemic stroke – background and clinical applications | Neurological Research and Practice | 2019 | 51 |
| 8 | Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients | Neurological Research and Practice | 2021 | 44 |
| 9 | Guideline “diagnosis and non interventional therapy of neuropathic pain” of the German Society of Neurology (deutsche Gesellschaft für Neurologie) | Neurological Research and Practice | 2020 | 39 |
| 10 | Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016 | Neurological Research and Practice | 2019 | 38 |
| 11 | Diagnosis and treatment of neurogenic dysphagia – S1 guideline of the German Society of Neurology | Neurological Research and Practice | 2021 | 38 |
| 12 | An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial | Neurological Research and Practice | 2019 | 35 |
| 13 | Prevention of migraine with monoclonal antibodies against CGRP or the CGRP receptor | Neurological Research and Practice | 2020 | 35 |
| 14 | Neurological manifestations of COVID-19 – an approach to categories of pathology | Neurological Research and Practice | 2021 | 35 |
| 15 | Molecular mechanisms of proteinopathies across neurodegenerative disease: a review | Neurological Research and Practice | 2019 | 33 |
| 16 | Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | 2022 | 27 |
| 17 | Prognostication after intracerebral hemorrhage: a review | Neurological Research and Practice | 2021 | 26 |
| 18 | Guillain-Barré syndrome and SARS-CoV-2 | Neurological Research and Practice | 2020 | 25 |
| 19 | Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage | Neurological Research and Practice | 2019 | 24 |
| 20 | The German trial on Aciclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis (GACHE): a multicenter, randomized, double-blind, placebo-controlled trial | Neurological Research and Practice | 2019 | 23 |
| 21 | Vojta therapy improves postural control in very early stroke rehabilitation: a randomised controlled pilot trial | Neurological Research and Practice | 2020 | 23 |
| 22 | S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version) | Neurological Research and Practice | 2020 | 23 |
| 23 | Acute ischemic stroke care in Germany – further progress from 2016 to 2019 | Neurological Research and Practice | 2021 | 22 |
| 24 | Antibody-related movement disorders – a comprehensive review of phenotype-autoantibody correlations and a guide to testing | Neurological Research and Practice | 2020 | 21 |
| 25 | Comprehensive approaches for diagnosis, monitoring and treatment of chronic inflammatory demyelinating polyneuropathy | Neurological Research and Practice | 2020 | 20 |
| 26 | SOP: antibody-associated autoimmune encephalitis | Neurological Research and Practice | 2020 | 20 |
| 27 | Seizures and epilepsy in patients with ischaemic stroke | Neurological Research and Practice | 2021 | 20 |
| 28 | An unmet clinical need: roads to remyelination in MS | Neurological Research and Practice | 2019 | 19 |
| 29 | Post-COVID-19 encephalomyelitis | Neurological Research and Practice | 2021 | 19 |
| 30 | PIMIDES I: a pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy | Neurological Research and Practice | 2020 | 19 |
| 31 | Insomnia in neurological diseases | Neurological Research and Practice | 2021 | 18 |
| 32 | Emerging and re-emerging viruses affecting the nervous system | Neurological Research and Practice | 2019 | 17 |
| 33 | A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets | Neurological Research and Practice | 2020 | 17 |
| 34 | A neurologist’s rhombencephalitis after comirnaty vaccination. A change of perspective | Neurological Research and Practice | 2021 | 17 |
| 35 | Outcome evaluation by patient reported outcome measures in stroke clinical practice (EPOS) protocol for a prospective observation and implementation study | Neurological Research and Practice | 2019 | 16 |
| 36 | Inpatient TIA and stroke care in adult patients in Germany - retrospective analysis of nationwide administrative data sets of 2011 to 2017 | Neurological Research and Practice | 2019 | 16 |
| 37 | Impact of the COVID-19-pandemic on thrombectomy services in Germany | Neurological Research and Practice | 2020 | 16 |
| 38 | Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban | Neurological Research and Practice | 2021 | 16 |
| 39 | An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | 2021 | 16 |
| 40 | GCS 15: when mild TBI isn’t so mild | Neurological Research and Practice | 2019 | 15 |
| 41 | German guidelines on the diagnosis and treatment of neurosyphilis | Neurological Research and Practice | 2020 | 15 |
| 42 | Long-term recovery of upper limb motor function and self-reported health: results from a multicenter observational study 1 year after discharge from rehabilitation | Neurological Research and Practice | 2021 | 15 |
| 43 | Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA) | Neurological Research and Practice | 2019 | 14 |
| 44 | Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis | Neurological Research and Practice | 2020 | 14 |
| 45 | Gene specific therapies – the next therapeutic milestone in neurology | Neurological Research and Practice | 2020 | 14 |
| 46 | New alternative splicing variants of the ATXN2 transcript | Neurological Research and Practice | 2019 | 13 |
| 47 | Validation of a German version of the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale: preliminary version and study protocol | Neurological Research and Practice | 2020 | 13 |
| 48 | Immunoglobulins to mitigate paraneoplastic Lambert Eaton Myasthenic Syndrome under checkpoint inhibition in Merkel cell carcinoma | Neurological Research and Practice | 2020 | 13 |
| 49 | Autoimmune encephalitis in children and adolescents | Neurological Research and Practice | 2020 | 13 |
| 50 | Probability assessment of intracerebral hemorrhage in prehospital emergency patients | Neurological Research and Practice | 2021 | 13 |
